Herpes Labialis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Herpes Labialis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT01306084

Viral Infections in Healthy and Immunocompromised Hosts

Background: \- Viral infections are an important cause of illness and death in hospitalized patients as well as outpatients. New strains of viruses may appear…

United States1,000 participantsStarted 2011-03-15

All recent trials (58 shown)

CompletedPhase 2

NCT06558838

Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions

This will be a randomized, efficacy assessor-blinded, parallel group, pilot study of up to 40 subjects with documented herpes labialis. Patients will be treated…

United States40 participantsStarted 2024-08-19

Treatment: acyclovir-penciclovir cream, Abreva

CompletedPhase 2

NCT04893577

EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions

This will be a randomized, efficacy assessor-blinded, parallel group, pilot study of up to 20 subjects with documented herpes labialis. Patients will be treated…

United States10 participantsStarted 2022-01-20

Treatment: EDTA, Abreva

Herpes Labialis

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Viral Infections in Healthy and Immunocompromised Hosts

All recent trials (58 shown)

Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions

EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Viral Infections in Healthy and Immunocompromised Hosts

All recent trials (58 shown)

Efficacy and Safety of Acyclovir-penciclovir Cream Versus an Abreva in the Suppression of Herpes Simplex Virus Eruptions

EDTA Eye Drops Compared to Abreva for Herpes Simplex Virus Eruptions

A Study to Compare Sitavig (Acyclovir) Buccal Tablet With a Placebo in the Treatment of Herpes Labialis in Participants…

Post-marketing Study for the Evaluation of Profilm Cold Sores

Implementation of a Minor Ailment Service in Community Pharmacy Practice

Treatment of Herpes Labialis by Photodynamic Therapy

Hand Sanitizer Use for Herpes Simplex Virus-1

Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection

An Investigation Into the Efficacy of Herpecin L at Reducing the Frequency and Severity of Cold Sores

Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)

Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis

Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

Botulinum Toxin A for Herpes Labialis

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With R…

Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for Episodic Treatment of Cold Sores

Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers